-12%

est. 2Y upside i

HealthcareSeries A

Rank

#2576

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Low

Rupa Health's equity is difficult to evaluate due to the missing valuation and the 2024 acquisition by Fullscript; the estimated $75M entry valuation implies a 4.8x trailing revenue multiple, leaving severe preference overhang.

Last updated: August 4, 2026

Bull (20%)+86%

Fullscript integration accelerates growth to 25%+ and platform network effects drive a 7x forward revenue multiple, valuing Rupa at $147M. IPO window for parent unlocks liquidity, +86% net of dilution.

Base (50%)+2%

Revenue grows modestly to ~$21M and exit multiple fades to 4x, yielding a $84M valuation. With preference stack and dilution, common stock upside is roughly flat, +2%.

Bear (30%)-100%

Incumbent competition and slowing growth compress multiple to 2x, exit valuation $42M falls below $44.7M preferred claim, leaving zero for common stock.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

60%

Preferred holders have $44.7M claim, representing ~60% of the estimated $75M valuation.

Dilution Risk

moderate

No near-term Rupa-level raise likely, but Fullscript could issue shares and dilute minority holders.

Secondary Liquidity

none

No secondary market for Rupa shares; liquidity depends entirely on parent company exit.

Other — 2 roles

View all 2 open roles at Rupa Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Rupa Health's data — designed to show you've done your homework.

  • 1

    “What is the current revenue run-rate and growth rate for Rupa Health in 2026?”

  • 2

    “Will my equity grant be in Rupa Health shares or Fullscript shares, and what is the 409A valuation?”

  • 3

    “How does the acquisition by Fullscript impact Rupa's product roadmap and go-to-market strategy?”

Community

Valuation Sentiment

Our model estimates -12% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.